The prefilled syringe drug molecule market is poised for significant expansion, with projected sales expected to increase from USD 70,177.9 million to USD 125,678 million, reflecting a compound annual growth rate (CAGR) of 6% between 2024 and 2034. This remarkable sales surge is primarily driven by the growing trend of self-administration, an increasing demand for …